Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
Dimitriadis E, Daskalakis M, Kampa M, et al
Your treatment plan Treatment often begins with Tier 1 and may be adjusted over time based on your progress, goals, and clinician guidance
Quick Answer: Lightheadedness on tirzepatide typically results from dehydration due to gastrointestinal side effects, hypoglycemia when combined with insulin or sulfonylureas, medication interactions affecting blood pressure, or orthostatic hypotension from weight loss
This is especially true if you have diabetes, cardiovascular conditions, thyroid disorders, or kidney disease, all of which can be affected by changes in GLP-1 receptor agonist therapy
Increasing glutathione levels may clean your acne by neutralizing oxidative stress and promoting skin regeneration